NeoGenomics

+$0.11 (+0.26%) Today
+$0.10 (+0.24%) As of 9:49 AM UTC after-hours

Why Robinhood?

You can buy or sell NeoGenomics and other stocks, options, and ETFs commission-free!

About NEO

NeoGenomics, Inc. Common Stock, also called NeoGenomics, is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services.

CEO
Mark Mallon
Employees
1,700
Headquarters
Fort Myers, Florida
Founded
1998

NEO Key Statistics

Market Cap
5.58B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
879.86K
High Today
$42.12
Low Today
$39.75
Open Price
$41.30
Volume
1.90M
52 Week High
$61.57
52 Week Low
$25.19

NEO Earnings

-$0.14
-$0.01
$0.12
$0.25
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 13, Pre-Market
Replay Earnings Call

You May Also Like

UTHR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure